AES in Medical News

96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy

...s. 14 percent), cough (11 percent vs. 9 percent) and herpes simplex (10 percent vs. 10 percent). The incidence of nervous system and psychiatric aes was comparable between the INTELENCE and placebo arms. Nineteen percent of patients in the INTELENCE arm experienced nervous system disorders and 20 p...

InfoWallet, A New Innovative Secure, Portable, Multi-Platform, Personal Life Manager Software Is Now Available

...llet supports the most popular and robust world class strong-encryption schemes for absolutely bullet-proof information security. InfoWallet supports: aes encryption at 128, 192, and 256 bits, Blowfish at 128, and 448 bits, TripleDES 192 bit InfoWallet tracks visits to each doctor and all resulting p...

Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis

...,152 to 31,431 umol in the four treatment groups There were no SAEs or aes leading to withdrawal during the study. The most common system organ class ...ions" (32 events in 18 subjects), and of these the most frequent individual aes were increased body temperature, which was reported in 10 subjects (all fro...

Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives

...he patient. ADVERSE REACTIONS Adverse events (AE) after administration of RhoGAM and MICRhoGAM are rare. The most frequently reported aes are anti-D formation and injection site reactions, such as swelling, induration, redness and mild pain or warmth. Possible systemic reactions are skin...

GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer

...abine refractory group (n=79).(5,6) The most common adverse events (AEs) seen with ofatumumab were related to infusion reactions and infections. aes seen in at least 10 percent of patients included fever, cough, diarrhea, rash, low white blood cell counts, fatigue, pneumonia, anemia, shortness of b...

InterMune Reports Results from Triple Combination Study of ITMN-191

...ents (SAE) or Grade 4 adverse events (AEs) during treatment with ITMN-191. aes reported during study treatment (ITMN-191 or placebo) were predominantly mi...e (SOC) and none led to treatment discontinuation. Only four Grade 3 aes were reported during study treatment, two of which (sciatica and back pain)...

Berkshire Medical Center Selects Desktop Alert for Mass Notification Solutions

...digital signage devices. Desktop Alert securely extends alerting to personal computers outside the network by the utilization of Protexx 256 Bit aes digital encryption certificates which protects data in motion thus providing the ability to instantly allow secure external connectivity for remote em...

Berkshire Medical Center Selects Desktop Alert for Mass Notification Solutions

...digital signage devices. Desktop Alert securely extends alerting to personal computers outside the network by the utilization of Protexx 256 Bit aes digital encryption certificates which protects data in motion thus providing the ability to instantly allow secure external connectivity for remote em...

New Research Reports on Interventions that May Alter the Course of Epilepsy Diagnosis and Management

...epsy management. Three studies highlighted at the aes annual meeting address this goal from different va...and treat epilepsy," said Dennis D. Spencer, M.D., aes President, Harvey and Kate Cushing Professor and C...sures in Epilepsy Monitoring Units A new aes survey of physicians and nurses provided the basis...

New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes

...nces of overall adverse experiences (AEs), serious aes and aes leading to discontinuation were 46 and 53 percent,...and 13 percent and 5 and 3 percent. Clinical aes of hypoglycemia and selected gastrointestinal (GI)...

US FDA Approves 30-Minute Onset of Action for Focalin(R) XR, Bringing Potential Benefits to ADHD Patients During Early Morning Period

....4% Focalin XR vs. 22.1% placebo). The most common aes (>/= 2% patients during double-blind treatment) we...ncreased appetite, and viral gastroenteritis. Most aes were reported as mild (15% Focalin XR; 17% placebo... while receiving Focalin XR. There were no serious aes reported or discontinuations due to AEs. Focalin...

New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation

...fferent from placebo (p=0.18). The study also demonstrated that once-daily extended-release memantine was well tolerated. The treatment-emergent aes (TEAEs) profile was similar between the groups; no TEAEs were experienced by e 5% of memantine patients, and at an incidence at least twice that of th...

Long-term safety data on Lialda published in leading GI journal

...(AEs), treatment exposure, and time to withdrawal. aes refer to any untoward medical occurrence that happens in a clinical trial patient. aes can be "treatment-related" (TRAEs) and occur as a ...red unrelated to the study drug. In study 303, all aes were classified in one of three categories accordi...

Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal

...(AEs), treatment exposure, and time to withdrawal. aes refer to any untoward medical occurrence that happens in a clinical trial patient. aes can be "treatment-related" (TRAEs) and occur as a ...red unrelated to the study drug. In study 303, all aes were classified in one of three categories accordi...

TAK-390MR Phase 3 data presented at Digestive Disease Week

...igher overall healing than those taking lansoprazole with a similar rate of aes across groups, said Dr. Prateek Sharma, professor of medicine, gastroentero...ys for patients treated with placebo. The most frequent treatment related aes for patients in the six-month maintenance study taking TAK-390MR included f...

Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms

...h INTUNIV and 71.8 percent of patients treated with placebo. Overall, the aes were mostly mild to moderate in severity. Adverse reactions that appeared ...ion, dizziness, dry mouth, hypotension, sedation, and somnolence. Serious aes reported in these analyses were uncommon and rates were similar between pa...

Intronis Technologies to Launch Partner Enablement Program at INTEROP 2008

...ers to schedule backups according to unique business rules. To ensure complete privacy of the users' data, eSureIT incorporates military grade 256-bit aes security encryption. Coupled with a remote mirrored site archiving capability to guarantee high availability and accessibility to customer data, partn...

Omron Healthcare Develops Solar-Powered Digital Blood Pressure Monitors

...ardless of proximity to an electrical supply source. The products feature aes (*1) plastic material, which is durable against UV light; an important comp...mpany through the creation of products such as the HEM-SOLAR Series. *1 aes plastic resin = Acrylonitrile/ Ethylene-propylene-diene/ Styrene plasti...

Ustekinumab Phase 3 data show long-term improvement of chronic plaque psoriasis

...with 45 mg and 90 mg ustekinumab, respectively, experienced at least one AE, compared with 56 and 48 percent of patients switched to placebo. Serious aes were observed in 0 and 1 percent of patients continuing treatment with 45 mg and 90 mg ustekinumab, compared with 0 and 2 percent of patients switched...

GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder

...dverse event (AE) observed in this study was headache, reported in 8% and 11% of patients receiving eltrombopag and placebo respectively. Other common aes occurring in at least 5% of eltrombopag subjects included nausea, nasopharyngitis, diarrhea and vomiting. About the Phase II Data(4) The Phase I...

Yale Neurosurgeon Named American Epilepsy Society President

...rganization's 61st annual meeting in Philadelphia. aes is the professional society for physicians and sci...y develops. Dr. Spencer has been a member of the aes board of directors since 2003 and served on its Su...ncluding three million in the United States. The aes annual meeting at the Philadelphia Convention Cent...

Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia

...itive symptoms. The majority of patients (83% asenapine, 79% placebo, 90% risperidone) experienced at least one adverse event (AEs) during the study. aes were generally mild to moderate in severity. The most commonly reported AEs (greater than or equal to 10% of the patients) were: insomnia, somnolence,...

Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C

...ents (AEs) reported shows the highest incidence of aes was in the placebo group with 34 events in 7 of 8 ...treatment in patients receiving R7128, most of the aes reported were of mild intensity. Eighteen aes were reported in 7 of 8 subjects that received 750...

AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure

... be expected. Adverse Events The withdrawal rates due to adverse events (AEs) were similar with Benicar to placebo: (2.4% vs 2.7%). The incidence of aes with Benicar was similar to placebo. The only AE that occurred in >1% of patients treated with BENICAR and more frequently than placebo was dizziness ...

Pazopanib Shows Positive in Advanced Renal Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma

... nine (41%) of 22 evaluable patients with relapsed disease. The most common aes were diarrhea, nausea, abdominal pain, fatigue, and vomiting. Please see sa...further investigate activity in the responsive tumor types. The most common aes recorded were hypertension, fatigue, hair color change, and nausea. Please ...